Completed PHASE4 INTERVENTIONAL 3-arm NCT03048383

Comparison of Three Botulinum Neuromodulators for Management of Facial Synkinesis

Randomized, Single-blind Comparison of Three Commercially Available Botulinum Neuromodulators in the Management of Facial Synkinesis

Sponsor: University of Utah

Conditions Facial Asymmetry Facial Nerve Injuries Facial Paresis Associated With Facial Nerve Dysfunction Synkinesis

Interventions AbobotulinumtoxinA Injectable Product Incobotulinumtoxin A Injectable Product OnabotulinumtoxinA Injectable Product

Updated 9 times since 2017 Last updated: Jun 29, 2017 Started: Jul 31, 2012 Primary completion: Mar 31, 2015 Completion: Mar 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03048383, this PHASE4 trial focuses on Facial Asymmetry and Facial Nerve Injuries and remains completed. Sponsored by University of Utah, it has been updated 9 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Dec 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 4 earlier versions

Jan 2021 — Dec 2021 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Sep 2017 — Jun 2018 [monthly]

Completed PHASE4
Feb 2017 — Sep 2017 [monthly]

Completed PHASE4

First recorded

Jul 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Utah

Data source: University of Utah

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.